SpaceX's Nasdaq Strategy Could Reshape Mega-Cap IPO Landscape
SpaceX's potential Nasdaq listing with immediate $NDX inclusion could redefine how mega-cap IPOs access institutional liquidity and passive capital flows.
Fed Trapped at 3.50-3.75% as Iran Conflict Ignites Oil-Fueled Inflation Shock
The Fed's 3.50-3.75% rate hold faces stress tests as Middle East conflict drives energy volatility and sticky inflation above the 2% target.
Oracle's Cloud Ascendancy: Can It Weather the AI Storm?
Vertex's Kidney Trial Win: Progress or Peril for Biotech Bulls?
Vertex Pharmaceuticals surged 4% on rare disease trial success, but investors should weigh pipeline risks against diversification hopes.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.